Home Tags Technology Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot (TEMPO)

Tag: Technology Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot (TEMPO)

Also Noted

FDA selects Dexcom for digital health pilot

July 29, 2026HME News Staff

WASHINGTON – The U.S. Food and Drug Administration (FDA) has selected Dexcom as the first participant in its Technology-Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot, or TEMPO. The pilot, conducted in partnership with the CMS Innovation Center, is designed to evaluate how digital health technologies perform in real-world settings while expanding access to technology-enabled care for people with Medicare. The program is intended to help patients participating in CMS’s...

Dexcom, Food & Drug Administration (FDA), Technology Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot (TEMPO)

Read Full Articlered right arrow icon